Professional Documents
Culture Documents
Digoxin Toxicity
Digoxin Toxicity
PGI Silan
Digoxin Toxicity
• Harrisons Principles of IM
• Chap. 450 Poisoning and Drug
Overdose
• Physiologic depression
• Sympatholytic/
Parasympathomimetic
• Decreased pulse, blood pressure,
respiratory rate, temperature,
and neuromuscular activity
• Cardiac arrhythmias and
conduction disturbances
Digoxin
• Cardiac glycoside
• MOA: Inhibition of cardiac Na+, K+-ATPase membrane pump
• Metabolism: 60%-kidneys, 40%-liver
• Clinical Uses:
• Heart Failure – positive inotropic effect (Increased Ca → Increased
cardiac contractility)
• Atrial Fibrillation – parasympathomimetic effect → rate control
• Has a narrow therapeutic window
• Minimum effective concentration is about 1 ng/mL (Pt: 1.23 ng/mL)
Digoxin Toxicity
• Clinical Features:
• Gastrointestinal, psychiatric, and visual symptoms
• Atrioventricular block with or without concomitant
supraventricular tachyarrhythmia
• Ventricular tachyarrhythmias
• Hyperkalemia in acute poisoning
• Toxicity occurs at lower drug levels in chronic poisoning than in acute
poisoning.
Digoxin Toxicity
• Diagnosis:
• Labs – Hyperkalemia in acute poisoning (>5.5 mEq/L)
• ECG – Downsloping ST depression (Salvador Dali sign), flattened,
inverted, or biphasic T waves, shortened QT interval
• Toxicologic analysis